SCHEMBL13474692

SCHEMBL13474692

Oc1cccc2cccccccnc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.83
MMP2 P08253 2/20 0.83
METAP2 P50579 2/20 0.83
CHRM1 P11229 1/20 0.83
COMT P21964 1/20 0.83
ADRA1A P35348 1/20 0.83
METAP1 P53582 1/20 0.83
HDAC8 Q9BY41 1/20 0.83
KDM4E B2RXH2 10/20 0.69
ALOX12 P18054 4/20 0.69
ALDH1A1 P00352 4/20 0.69
LMNA P02545 3/20 0.69
KMT2A Q03164 5/20 0.57
TDP1 Q9NUW8 3/20 0.57
TP53 P04637 2/20 0.57
ALOX15 P16050 2/20 0.57
HTT P42858 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
RAB9A P51151 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxyquinoline SCHEMBL28191778 0.93 TSHR (0.95) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL12492889 0.91 TSHR (0.91) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL27529898 0.91 TSHR (0.91) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL37189 0.91 TSHR (1.00) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL29365411 0.91 TSHR (1.00) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL29716519 0.91 TSHR (1.00) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL253313 0.91 TSHR (1.00) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL29100483 0.90 TSHR (0.81) TSHRMMP2METAP2CHRM1COMT
Biphenyl SCHEMBL28254465 0.90 TSHR (0.81) TSHRMMP2METAP2CHRM1COMT
Oxyquinoline SCHEMBL23522696 0.89 TSHR (0.95) TSHRMMP2METAP2CHRM1COMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2514423-A2 Method of treatment of age-related macular degeneration (AMD) Prana Biotechnology Ltd (AU) 2012-10-24 EP disclosed